Communication and Hospice Online With Optimal Support and Engagement (CHOOSE)
Communication and Hospice Online With Optimal Support and Engagement (CHOOSE)
Обзор исследования
Статус
Статус
Условия
Условия
Вмешательство/лечение
Вмешательство/лечение
Тип исследования
Тип исследования
Регистрация (Оцененный)
Регистрация
Фаза
Фаза
- Непригодный
Контакты и местонахождение
Контакты исследования
Контакты исследования
- Имя: Debra P Oliver, PhD, MSW
- Номер телефона: 314-747-5357
- Электронная почта: oliverd@wustl.edu
Места учебы
-
-
Missouri
-
St Louis, Missouri, Соединенные Штаты, 63110
- Washington University School of Medicine
-
Контакт:
- Debra P Oliver, PhD, MSW
- Номер телефона: 314-747-5357
- Электронная почта: oliverd@wustl.edu
-
Главный следователь:
- Debra P Oliver, PhD, MSW
-
Младший исследователь:
- Jacquelyn Benson, PhD
-
Младший исследователь:
- Masako Mayahara, PhD
-
Младший исследователь:
- Amy McQueen, PhD
-
Младший исследователь:
- Eberechi Nwogu-Onyemkpa, MD
-
Младший исследователь:
- Kyle Pitzer, PhD
-
Младший исследователь:
- Karla Washington, PhD
-
-
Критерии участия
Критерии приемлемости
Критерии приемлемости
Возраст, подходящий для обучения
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Описание
Eligibility Criteria:
- Family caregiver of cancer patient receiving hospice care from an affiliated hospice organization. Only 1 FCG per patient may be enrolled.
- At least 18 years of age.
- Can speak and understand English.
- Able to access the internet.
- Has a Facebook account or is willing to create a Facebook account in order to be in this study
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Исследования в области здравоохранения
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Нет (открытая этикетка)
Количество рук
Оружие и интервенции
Группа участников / АрмияГруппа участников / Армия |
Вмешательство/лечениеВмешательство/лечение |
|---|---|
|
Активный компаратор: Usual Care (UC)
Patients randomized to the UC arm will receive the standard of care of intermittent hospice team support.
|
Intermittent hospice team support will be provided per standard of care guidelines.
|
|
Активный компаратор: Usual Care Online Social Support (UCOSG)
Patients randomized to the UCOSG arm will have access to an online support group in addition to the standard of care of intermittent hospice team support.
The online support group is led by an untrained facilitator.
|
Intermittent hospice team support will be provided per standard of care guidelines.
The online support group will be held via private, hidden Facebook.
The online support group will be led by an untrained facilitator whose role is to enroll participants and maintain guidelines.
Specifically, the untrained facilitator has the following roles: enrolls individuals in the group, monitors the discussion to maintain the guidelines to protect the group's integrity, provides information on resources for technical assistance, and notes any outside online groups to which they belong.
|
|
Экспериментальный: CHOOSE Intervention
Patients randomized to the CHOOSE intervention will have access to standard of care of intermittent hospice team support and access to an online support group led by a trained facilitator.
|
Intermittent hospice team support will be provided per standard of care guidelines.
The online support group will be held via private, hidden Facebook.
The online support group led by a trained facilitator focuses on building safe communication and encouraging participant engagement.
The trained facilitator has the following roles: enrolls individuals in the group, monitors the discussion to enforce the guidelines and protect the group's integrity, provides technical assistance, moderates group discussions, initiates threads using direct and indirect strategies and communication topic openings, builds a safe environment for communication, encourages participation, and organizes and coordinates Facebook Live activities.
|
Что измеряет исследование?
Первичные показатели результатов
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Changes in Patient Health Questionnaire (PHQ-9) score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The PHQ-9 is a 9-item questionnaire that assesses patient depression.
The 9-items are ranked by Likert Scale from 0 - Not at all, 1 - Several days, 2 - More than half the days, and 3 - nearly every day.
Scores range from 0-27 with lower scores indicating no or minimal depression and higher scores indicating moderate to severe depression.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in General Anxiety Disorder (GAD-7) score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The GAD-7 includes 7-items ranked by Likert scale to measure anxiety severity over the past two weeks.
Each item is ranked by 4-point Likert scale as follows: 0-Not at all, 1-Several days, 2-More than half the days, and 3-Nearly every day.
Scores range from 0-21, with a higher score indicating higher anxiety.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
Вторичные показатели результатов
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Changes in Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Well Being Domain Score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The PROMIS Physical Well Being Domain measures mobility and ability to perform daily activities and is taken from the PROMIS Scale v1.2 Global Health.
The domain contains four-items ranked on various Likert scales.
One-items addressing general physical health is ranked on a 5-point Likert Scale from 5-Excellent to 1-Poor.
One item addressing physical activities is ranked on a 5-point Likert scale from 5-Completely to 1-Not all.
One item addressing fatigue is ranked on a 5-point Likert scale from 5-None to 1-Very Severe.
One item addressing pain on average is ranked from a scale from 0-no pain to 10-worst pain imaginable.
Scores range from 0-50 with higher the score indicates higher physical function.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in PROMIS Mental Well Being Score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The PROMIS Mental Well Being score is taken from four-times on the PROMIS Scale v1.2 Global Health.
The 4 item sub-scale are administered using 5-point Likert Scale.
Three items are ranked on a 5-point Likert Scale from 5-Excellent to 1-Poor.
One item addressing emotional problems is ranked on a 5-point Likert scale from 5-Never to 1-Always.
Scores range from 0-50 and generally the higher the score indicates greater mental well-being.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in University of California Los Angeles (UCLA) Loneliness Scale-3 score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The UCLA Loneliness Scale-3 is a 3-item scale that assesses loneliness.
Each item is assessed by a 3-point Likert scale as follows: 1-Hardly ever, 2-Some of the time, and 3-Often.
Scores range from 3-9, with the lower the scores indicating less loneliness.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in Zarit Burden-7 Interview score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The Zarit Burden-7 is a 7-item interview used to measure strain in family and informal caregivers.
Each item is ranked using a 5-point Likert scale from 0 (Never) to 4 (Nearly Always).
Total score ranges from 0-42.
Generally, higher scores indicate a higher level of burden.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in Caregiver Quality of Life Index-Revised (CQLI-R) score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The CQLI-R contains four-items ranking physical, financial, emotional, and social quality of life.
Each item is ranked from 0 to 10 by the caregiver with 0 representing lowest quality of life and 10 representing highest quality of life.
Total scores range from 0 to 40 with lower scores indicating lower quality of life to higher scores indicating higher quality of life.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in Interpersonal Support Evaluation List (ISEL-SF) score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The ISEL-SF measures perceived social support.
The domain contains 12-items with four subscales.
Each item is ranked on a 4-point scale as follows: 3-definitely accurate, 2-probably true, 1-probably false, and 0-false).
Total scores range from 0 to 48 with higher scores indicating higher levels of perceived social support.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in Online Social Support Scale (OSS) score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The OSS is a 40-item measure assessing the perception of how well social support needs are met with the online group.
Items are scores with a 5-point Likert scale as follows: 0 = never, 1 = rarely, 2 = sometimes, 3 = pretty often, 4 = alot.
Total score range from 0-160.
Higher scores indicate more social support.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in The Group Identification Scale (GIS)
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The GIS is 4-item scale that measures the expression of shared identity within the online support group.
Each question is ranked according to a 7-point Likert scale from 1= strongly disagree to 7 = strongly agree.
Final score is the average of the four questions and ranges from 0-7.
The higher the score indicates a higher sense of shared identity.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in the Social Disconnectedness Perceived Isolation (SDPI) Social Disconnectedness subscale score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The SDPI is a 17-item scale that measures feelings of disconnectedness and isolation. The SDPI has two subscales: Social Disconnectedness Scale and Perceived Isolation Scale. The Social Disconnectedness Scale contains 8-items and measures physical ties. Items include contact frequency and self-reported numbers. All items are scored by taking an average. Scores have generally ranged from -1.30 to 2.34 with lower scores indicated more connectedness and higher scores indicating more disconnectedness. |
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in Social Disconnectedness Perceived Isolation (SDPI) Perceived Isolation Subscale score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The SDPI is a 17-item scale that measures feelings of disconnectedness and isolation. The SDPI has two subscales: Social Disconnectedness Scale and Perceived Isolation Scale. The Perceived Isolation Scale includes 9-items that measure loneliness and social support. Six-items assesses social support and are ranked on a 3- or 4-point Likert scale. Three-items are included from the UCLA Loneliness Scale assessed by a 3-point Likert scale as follows: 1-Hardly ever, 2-Some of the time, and 3-Often. Higher overall final scores indicate greater intensity of perceived isolation. |
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Changes in Facebook intensity scale score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The Facebook intensity scale is an 8-item scale that measures active Facebook use and emotional connection to Facebook and integration of Facebook into daily life.
Two questions assess number of Facebook friends and time spent on Facebook.
Six of the eight questions use a 5-point Likert scale ranked from 1-5 (1= strongly disagree to 5 = strongly agree).
The higher the score indicates the participant's engagement and usage of Facebook is greater.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
|
Count of Direct and indirect thread sequences
Временное ограничение: Throughout timeline of trial (estimated time 3 months)
|
Threads refer to the communication posts within online support groups and thread sequences are scenarios to coordinate communication. Thread sequences are categorized as indirect or direct strategies. A direct strategy is categorized as an initial post to open discussion by the facilitator. Indirect strategy is categorized as a reply to a facilitator to invite further discussion. There are four direct and four indirect sequence scenarios for a total of eight scenarios to analyze family caregivers' response and interaction. Thread sequences will be reported for indirect and direct thread sequences. |
Throughout timeline of trial (estimated time 3 months)
|
|
Changes in Safety Questions score
Временное ограничение: Baseline and every 14 days until completion of study (estimated total time 3 months)
|
The Safety Question Questionnaire is a 2-question survey to assess the perception of safe communication in the online support group.
The survey uses a 6-point Likert scale ranked from 0-5 (0=disagree and 5=strongly agree).
Total score range from 0-10.
Generally, the higher the score indicates a higher perception of safety.
|
Baseline and every 14 days until completion of study (estimated total time 3 months)
|
Соавторы и исследователи
Спонсор
Спонсор
Соавторы
Соавторы
Следователи
Следователи
- Главный следователь: Debra P Oliver, PhD, MSW, Washington University School of Medicine
Публикации и полезные ссылки
Даты записи исследования
Изучение основных дат
Начало исследования (Оцененный)
Начало исследования
Первичное завершение (Оцененный)
Первичное завершение
Завершение исследования (Оцененный)
Завершение исследования
Даты регистрации исследования
Первый отправленный
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Первый опубликованный
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее опубликованное обновление
Последнее отправленное обновление, отвечающее критериям контроля качества
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Другие идентификационные номера исследования
Другие идентификационные номера исследования
- 202606091
- 1R01CA315474-01 (Грант/контракт NIH США)
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Описание плана IPD
Сроки обмена IPD
Data will be available no later than at the time of publication or by the end of the award period, whichever occurs earlier. The duration of data preservation and sharing will be governed by the retention policies of Digital Commons Data@Becker.
Currently, the retention policy of Digital Commons Data@Becker ensures perpetual availability of all data shared in the repository, with contingency plans in place for potential changes in repository hosting.
Критерии совместного доступа к IPD
Совместное использование IPD Поддерживающий тип информации
- STUDY_PROTOCOL
- САП
- МКФ
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .